Navigation Links
Multiple Campylobacter Genomes Sequenced

In 1995, the first complete bacterial genome sequence was published. Now, nearly 200 bacterial genomes have been completed, and a new one hits the scientific press most weeks. This burgeoning industry is not just scientific “stamp collecting,?however. Having all these genome sequences may provide useful clues about why some bacteria cause human disease, how to control their spread, and how to treat the infections caused by them. By comparing genome sequences, scientists can learn much more about what makes a bacteria tick than they can learn from a single sequence.

Derrick Fouts and his colleagues have taken this comparative approach with Campylobacter. Infection with a Campylobacter species is one of the most common causes of human bacterial gastroenteritis. In the US, 15 out of every 100,000 people are diagnosed with campylobacteriosis every year, and with many cases going unreported, up to 0.5% of the general population may unknowingly harbor Campylobacter in their gut annually. Diarrhea, cramps, abdominal pain, and fever develop within 2? days of picking up a pathogenic Campylobacter species, and in most people, the illness lasts for 7?0 days. But the infection can sometimes be fatal, and some individuals develop Guillain-Barré syndrome, in which the nerves that join the spinal cord and brain to the rest of the body are damaged, sometimes permanently.

Campylobacteriosis is usually caused by C. jejuni, a spiral-shaped bacterium normally found in cattle, swine, and birds, where it causes no problems. But the illness can also be caused by C. coli (also found in cattle, swine, and birds), C. upsaliensis (found in cats and dogs), and C. lari (present in seabirds in particular). Disease-causing bacteria generally get into people via contaminated food, often undercooked or poorly handled poultry, although contact with contaminated water, livestock, or household pets can also cause disease.

In 2000, C. jejuni was the first food-borne pathogen to b
'"/>

Source:PLoS Biology


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
3. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
4. OHSU researchers discover potential mechanism to repair brain damage linked to Multiple Sclerosis
5. Multiple genes permit closely related fish species to mix and match their color vision
6. Multiple malaria infection inhibits spread of parasite

Post Your Comments:
(Date:11/9/2009)... marine plants called phytoplankton are flourishin...t and rapid melting of ice shelves and glaciers ar...nisation is having a beneficial impact on climate ... to the sea-bed where it can store carbon for thou...ek in the journal Global Change Biology , scienti...
(Date:11/9/2009)...ren with cancer, the hopeful news is that pediatri...s. Among the bad newstreatments that enable surviv...ith cancer who have reached puberty currently have...e undergoing cancer treatment, they may have their...r boys, however, do not produce sperm, although th...
(Date:11/9/2009)...N.Y. Oncologists have had their hands tied becaus...ns that disable a protein called p53. As a critica...ncer-fighting operations within cells. When cells ...t be treated. , These tumors might be tough, bu...m Cold Spring Harbor Laboratory (CSHL). The chink ...
Breaking Biology News(10 mins):Antarctica glacier retreat creates new carbon dioxide store 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3FDA Clears a Test for Ovarian Cancer 4972 1FDA Clears a Test for Ovarian Cancer 4972 2Professor Uses H1N1 as a Teaching Tool 56956 1Professor Uses H1N1 as a Teaching Tool 56956 2Professor Uses H1N1 as a Teaching Tool 56956 3Muslim Coalition to Host D C Hearing on Health Care Reform 56951 1Muslim Coalition to Host D C Hearing on Health Care Reform 56951 2
...ease is available in Spanish . , The SUPERCABL...aterial Science of Barcelona (ICMAB-CSIC), at the ...nd the company Nexans, received the NOVARE Prize i...y ENDESA. The 500,000 prize will be invested in de...south of Europe and the most advanced in the world...
... MA, AND WASHINGTON, DCThe University of Massachus...f Washington announced today that they have entere...(LSE: OXB), a gene therapy company, that grants t...atent rights. , The technology was invented by ..., and Craig C. Mello, PhD, and their colleagues. T...
...tor-in-Chief of Experimental Biology and Medicine ...n for expansion of the journal and enhancement of ...ogy and Medicine (SEBM) into Asia. The plan, whic...ves bringing outstanding Asian researchers onto th...om amongst the leaders in Asian Biomedical Science...
Other Biology News:CSIC and UAB will build the most advanced superconductor cable for electricity network 2CSIC and UAB will build the most advanced superconductor cable for electricity network 3UMMS and CIW grant key RNAi rights to Oxford Biomedica 2Experimental Biology and Medicine announces expansion into Asia, opens new office 2Experimental Biology and Medicine announces expansion into Asia, opens new office 3
(Date:11/9/2009)... YORK, Nov. 9 "Micro cap and small...receive more broker sponsorship and exposure as a ... upturn in commodity-driven stocks like gold, silv...nt of The Haft Group, Inc, Manhattan based investo... small cap equities market in the US and Canada, a...
(Date:11/9/2009)... BEIJING, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Yo...e or "the Company") a leading manufacturer, develo... animal nutrient products in the,People,s Republic...uct a,conference call at 10:00 a.m. Eastern Time (...009 to discuss results for the quarter ended Septe...
(Date:11/9/2009)... DIEGO, Nov. 9 BioMed Re...t the company has received commitments from lender...red line of credit by $65 million to an aggregate ...s of the facility. The weighted-average effective... 1.35% as of September 30, 2009. The maturity date...
(Date:11/9/2009)... SCHIEDLBERG, Austria, November 9 ...rld have been working on the development of a,Brai...nication channel,between the brain and a computer....ts to communicate or to control devices in their e...t years some patients have been supervised by,the ...
Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2
...rmaceuticals Inc. (Nasdaq: VNDA ), a biopharmace...ercialization of clinical-stage product candidates...nced financial and operational results for the fir...rted a net loss of $6.5 million for the first quar...th quarter of 2008. Total expenses for the first ...
..., - Increases Accessibility to Market-Leading ...ing publisher of scientific, technical, and,medica...ay that ten new eBook,Specialty Collections have l...,its online clinical reference tool. This launch p...ialty content in Dermatology, Dermatologic Surgery...
...e as usual pending Nasdaq listing review , , REYK... DCGN ) announced that it has this evening recei...eview Council stating that the Council has called ...q Listing Qualifications Panel regarding the delis... Stock Market. Pending the completion of this revi...
Other Biology Technology:Vanda Pharmaceuticals Reports First Quarter 2009 Results 2Vanda Pharmaceuticals Reports First Quarter 2009 Results 3Vanda Pharmaceuticals Reports First Quarter 2009 Results 4Vanda Pharmaceuticals Reports First Quarter 2009 Results 5Vanda Pharmaceuticals Reports First Quarter 2009 Results 6Vanda Pharmaceuticals Reports First Quarter 2009 Results 7Vanda Pharmaceuticals Reports First Quarter 2009 Results 8Vanda Pharmaceuticals Reports First Quarter 2009 Results 9Vanda Pharmaceuticals Reports First Quarter 2009 Results 10Elsevier Launches Ten New eBook Specialty Collections on MD Consult 2Elsevier Launches Ten New eBook Specialty Collections on MD Consult 3Nasdaq Stays Suspension of Trading in deCODE Stock 2Nasdaq Stays Suspension of Trading in deCODE Stock 3
Acridine orange, hemizinc salt from Research Organics, Inc.
Acridine orange 10-nonyl bromide from AnaSpec
Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Wash Solution from CHEMICON
Biology Products: